Related Experiment Video

Updated: Dec 4, 2025

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

4.1K

Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic

A De Lima-Karagiannis1, P Juillerat2, S Sebastian3

  • 1Erasmus University Medical Center, Department of Gastroenterology and Hepatology, the Netherlands.

Journal of Crohn'S & Colitis
|October 21, 2020
PubMed

Insights

Caring for pregnant women with inflammatory bowel disease [IBD] during the COVID-19 pandemic presents unique challenges. This paper addresses key clinical questions to guide management for optimal maternal and fetal outcomes.

Area of Science:

  • Gastroenterology and Hepatology
  • Obstetrics and Gynecology
  • Infectious Diseases

Background:

  • The COVID-19 pandemic poses risks to all populations, with particular concern for vulnerable groups.
  • Pregnant women with inflammatory bowel disease (IBD) require careful management due to the complexities of balancing maternal health and fetal well-being.
  • Managing IBD during pregnancy often involves immunosuppressive medications, adding complexity during a pandemic.

Purpose of the Study:

  • To address critical questions encountered in daily clinical practice regarding the care of pregnant IBD patients during the COVID-19 pandemic.
  • To provide evidence-based guidance for healthcare providers managing this specific patient population.

Main Methods:

  • This paper synthesizes current knowledge and expert opinion.
  • It focuses on answering practical clinical queries relevant to the management of pregnant IBD patients amidst the COVID-19 outbreak.

Main Results:

  • The paper discusses the implications of COVID-19 on pregnant IBD patients.
  • It provides insights into medication management, disease monitoring, and potential risks.
  • Guidance is offered on optimizing care strategies.

Conclusions:

  • Effective management of pregnant IBD patients during the COVID-19 pandemic requires a tailored approach.
  • Addressing specific clinical questions is crucial for ensuring the best possible outcomes for both mother and child.
  • Continued vigilance and adaptation of care protocols are necessary.

Keywords:
PregnancyCOVID-19SARS-CoV2inflammatory bowel disease

More Related Videos

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice05:24

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice

Published on: October 10, 2025

181
Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C07:13

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C

Published on: March 25, 2016

19.2K

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
530
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
321
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
329
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
313
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
354
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
725